Status:
UNKNOWN
A Safety and Efficacy of Homeopathic Medicine Rhus Toxicodendron 30 in the Treatment of Rheumatoid Arthritis
Lead Sponsor:
Healthcare Homoeo Charitable Society
Conditions:
Rheumatoid Arthritis.
Eligibility:
All Genders
25-60 years
Phase:
PHASE2
Brief Summary
the purpose of the study is to assess the safety and efficacy of commonly used Homeopathic medicine Rhustoxicodendron in 30 potency in the treatment of Rheumatoid arthritis.
Detailed Description
it is a multicenter phase 2 ,double blind study in patient with active Rheumatoid arthritis ,there are 2 group in the study A and B ,where group A receive Rhustoxicodendron in 30 potency the first dos...
Eligibility Criteria
Inclusion
- those who will provide written consent to participate in the study
- patient willing to turn up for 7th day follow up
- patient who are willing and compliance to the study
- those who are between 25 to 60 years .
- patient who are willing and compliance to the study .
- ESR more then 28 mm.
Exclusion
- Participating as a subject in any other clinical research study.
- Children below the age of 25years.
- Female subject who are pregnant or planning for pregnancy within 6 month.
- History of seizures
- Breast feeding women's.
- Patient on treatment for life threatening illness like cancer aids etc.
- Patient should not have any congenital abnormality or patient should not have undergone any operative procedure as consequences of RA.
Key Trial Info
Start Date :
August 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2014
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT01905735
Start Date
August 1 2013
End Date
February 1 2014
Last Update
August 2 2013
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Gupta Homoeo Clinic
Delhi, National Capital Territory of Delhi, India
2
Kochhar Clinic
Ludhiana, Punjab, India, 141001